Generic and brand-name drugs T
Trajenta is indicated for the treatment of type 2 diabetes mellitus (T2DM) in adult patients to improve glycemic control, glycemic control monotherapy, or in combination with metformin, with pioglitazone or a sulfonylurea, with insulin.
Trajenta Duo is indicated for the treatment of type 2 diabetes mellitus and should be treated concomitantly with linagliptin and metformin. Trajenta Duo is indicated in combination with a sulphonylurea (ie a 3-drug regimen) along with an appropriate regimen.
Troxevasin is indicated for the relief of swelling and symptoms associated with chronic venous insufficiency, along with elastic compression stockings in varicose dermatitis, in the combined treatment of varicose ulcers.
Twinrix immunizes against hepatitis A and hepatitis B infections by generating specific antibodies to HAV and anti-HBs. Twinrix is indicated for immunocompromised individuals who are at risk for both hepatitis A and hepatitis B infection.
Twynsta for the treatment of essential hypertension. Patients taking telmisartan and amlodipine individually can be substituted with Twynsta containing the same strength and composition of drugs.